Alexandre FONTAYNE received his PhD in Biological Science at University of Paris Sud. He has 18 years of experience in Research and Development, including 13 years in the pharmaceutical industry working around the drug design and bioproduction of biologics, including Ublituximab. Alexandre is co-author of 28 scientific articles and inventor of 11 patents in multidisciplinary approach. He contributes to training of students and employees in drug design, CMC activities and subcontracting. Since 2021, Alexandre works for Unither Pharmaceuticals as Chief Scientific Officer for biological products and is deeply involved in the development of the Euroject® device.
Menu
Menu